"10.1371_journal.pone.0086961","plos one","2014-01-30T00:00:00Z","Kensuke Kojima; Craig April; Claudia Canasto-Chibuque; Xintong Chen; Manjeet Deshmukh; Anu Venkatesh; Poh Seng Tan; Masahiro Kobayashi; Hiromitsu Kumada; Jian-Bing Fan; Yujin Hoshida","Liver Cancer Program, Tisch Cancer Institute, Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Illumina, Inc., San Diego, California, United States of America; Department of Hepatology, Toranomon Hospital, Tokyo, Japan","Conceived and designed the experiments: CA JBF YH. Performed the experiments: CA CCC MD JBF YH. Analyzed the data: KK CA XC JBF YH AV PST. Contributed reagents/materials/analysis tools: MK HK. Wrote the paper: KK CA JBF YH.","YH is a named investigator on a patent application entitled Compositions, kits, and methods for detecting, characterizing, preventing, and treating hepatic disorders (USPTO application number: #20110263441). NanoString, Inc. has secured the option to an exclusive worldwide license. There is no other relevant declaration relating to employment, consultancy, patents, products in development or modified products, etc. CA and JBF are employed by a commercial company, Illumina, Inc. There is no other relevant declaration relating to employment, consultancy, patents, products in development or marketed products, etc. YH is a PLOS ONE Editorial Board member. These do not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Kensuke Kojima","KK",11,TRUE,3,5,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
